CIDSCON 2023 Selected Abstracts
Journal of Clinical Infectious Diseases Society · 2023
DOI: 10.4103/3333-5555.380637 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Infectious Diseases Society, 2023. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
003 PUO in AIDS – An Unusual Case of Histoplasmosis Associated Reactive Hemophagocytosis: A Case Report Kalaimani Sivamani, Varun Dhir Department of Medicine, JIPMER, Puducherry, India Introduction: Pyrexia of unknown origin (PUO) in patients with Acquired Immunodeficiency Syndrome (AIDS) has a diverse etiology. While opportunistic infections and tuberculosis are the major causes, Histoplasmosis, an endemic mycosis, is infrequently considered due to a lack of awareness and diagnostic facilities. Here we present a rare case of disseminated histoplasmosis with secondary hemophagocytic lymphohistiocytosis (HLH) in an HIV patient with prolonged fever and pancytopenia who recovered with treatment. Case Report: A 34-year-old male, recently diagnosed to be HIV positive, not on ART, presented with fever of 4 months, cough, and progressive breathlessness for 20 days. Laboratory investigations showed anemia and thrombocytopenia with elevated liver enzymes. CD4 count was 29. CECT thorax showed multiple random centrilobular nodules in both lungs with mediastinal adenopathy. There was no clinical improvement with empirical antibiotics and antitubercular drugs. Bone marrow aspiration showed an increase in histiocytes, hemophagocytosis, and intracytoplasmic microorganisms corresponding to the morphology of Histoplasma capsulatum. The patient clinically improved with Liposomal Amphotericin B for 2 weeks, followed by oral itraconazole. ART was started after 2 weeks during follow-up.
Discussion
HLH is a disorder of dysregulated immune function which can be primary or secondary. In patients with HIV, many opportunistic infections (OI) have been associated with HLH. Less than 50 cases of histoplasmosis associated with HLH in HIV, including 2 cases from India, have been reported after the year 2000 with a mortality rate of around 30%. There are no specific guidelines for infection associated HLH. The prompt clinical improvement after starting antifungals and the improvement in cytopenias suggest that treating the underlying infection may be sufficient for the secondary HLH.
Conclusion
This case highlights histoplasmosis as an uncommon cause of HLH in patients with HIV infection, and physicians should search for it, particularly in patients with HIV who have features of hemophagocytosis.Bone marrow aspirate smear showing histiocyte with hemophagocytosis and Histoplasma capsulatum. 004 Grand Rounds with ChatGPT: A Qualitative Study on the Clinical Utility and Limitations of a Large Language Model in Infectious Diseases Raksha Kochhi, Pallavi Balaraman, Sara Ali Department of Central Laboratory, Bengaluru, Karnataka, India Background: Parallel to the evolution of microbes & infectious diseases, there has been a rapid evolution in the field of generative Artificial Intelligence Models. This has led to exploration of the potential for AI to replace physicians, prompting us to assess the role of one such Large Language Model (LLM) ChatGPT developed by Open AI. The study was motivated by a recent article by Howard et al from the University of Liverpool which was published in the Lancet Infectious Diseases in February 2023. Methodology: In this qualitative study assessed the clinical utility and limitations of ChatGPT in diagnosing infectious diseases. Sixty real-life cases of photo quizzes published in our CIDS monthly newsletter from 2017 to 2023 were typed verbatim, and prompt questions were given as per the LLM’s response. Two independent reviewers evaluated ChatGPT’s responses using a qualitative assessment framework [Figure 1].Figure 1: Chat bots and Diagnosis of Infectious Diseases- CIDS Cases & ChatGPTResults: ChatGPT’s responses were generally compelling, in clear and concise language with appropriate scientific terminologies and definitions. It suggested a clinical diagnosis with the line of management and theoretical aspects of the disease. However, in some cases, only a broader diagnosis was given, and specific findings were identified only on certain occasions. Rare presentations were correctly identified only after multiple levels of probing, while a few cases were misdiagnosed entirely due to unusual presentations. In some cases, the diagnosis varied on certain occasions when typing the case verbatim for the second time. These findings highlight the potential utility and limitations of ChatGPT as a diagnostic tool.
Discussion
While innovative AI tools like ChatGPT can be useful for references and as potential teaching learning techniques, they cannot replace specialists. ChatGPT lacks the essential human aspect of care, such as situational awareness, empathy, and emotion. Healthcare professionals should adapt to these technologies, utilize them as aids to accelerate and improve patient care. 005 Carbapenem-resistant Enterobacteriaceae Colonization in Liver Transplant Recipients in a Quaternary Care Centre-seek and Thou Shall Find Sweatha Kumar, Vidya Devarajan, Dinesh Jothimani, Akila Rajakumar, Subha Sundaramoorthy, Mohamed Rela Department of Infectious Disease, Dr. Rela Institute and Medical Centre, Chennai, Tamil Nadu, India Background: Carbapenem-resistant Enterobacteriaceae (CRE) is a global public health concern. Data on CRE in transplant recipients from India is sparse.Faecal carriage with CRE is an important risk factor for bacteraemia in immunocompromised hosts, particularly in patients with solid organ transplantation (SOT), hematologic malignancies, and stem cell transplant recipients. Approximately around 3%–10% of solid organ transplant (SOT) recipients from CRE-endemic regions develop CRE infection. Carbapenem-resistant Klebsiella pneumoniae accounts for infections in 1–18% of SOT recipients. Mortality rates of around 60% has been reported in this populations. Early diagnosis and rapid therapy initiation are critical in managing immunocompromised hosts with CRE infections, as recommended empiric regimens are ineffective against CRE. To prevent CRE infection a multidisciplinary approach is needed. It is necessary to develop risk-stratification tools for the management of these individuals.
Methods
Retrospective analysis was done to detect CRE colonization in all liver transplant recipients between January 2019 to May 2022. (1) Rectal swab screening method for Carbapenem resistance. Enterobacteriaceae (CRE) from Jan 2019 to April 2021 was done by CHROMID CARBASmart Agar (Biomerieux). CHROMID CARBA SMART agar is a selective chromogenic bi-plate media to screen for OXA-48 on one side and other CPE, notably KPC and NDM-1, on the other side. (2) Rectal swab screening method for Carbapenem-resistant. Enterobacteriaceae (CRE) from May 2021 to May 2022 was by XpertCarba – R. XpertCarba –R is a PCR that and the and in CRE screening by CHROMID CARBASmart Agar was in individuals. CRE screening by was done in individuals. CRE colonization was by CHROMID CARBA SMART agar in and in by was in was that of both and followed by was in followed by and and were in and were in one for CRE colonization may in empiric therapy during and appropriate infection Conclusion: for CRE colonization may in empiric therapy during and appropriate infection of Artificial Intelligence to of on a of of Department of Medicine, Medical India Background: we are in the year of by 2 a that and on patients by of the we that as in and teaching of in learning for the we to an to of patients our Methods: Artificial Intelligence of and and of we were to in and count the of patients of who have and of oral and of as to with to than was there on and were to by of for a certain oral and were managing and in during second 2 These in of and Conclusion: all the aspects of including and the is a and teaching and of and is a which we while to with our of of assessment and should be of this aspect as to some Infectious of the of not only in of the of on and in and A Study Kumar, R. Department of Central Laboratory, Bengaluru, Karnataka, India Background: and infections are a global health with and mortality of and is for treatment. However, and can in and the of to and in and to clinical utility of Methodology: In this study patients were in our and analysis of was The in and the of for clinical and the of in and and rates while and multiple rates from The of and rates for and for antibiotics and cases of Conclusion: The study the of such as and on and The in and rates to antibiotics highlights the of to to improve diagnosis and therapy is the of the 1: analysis of with of Data to of a in India during Kumar, Department of Medicine, Medical India Introduction: a as in our time. the of cases in a many were that to the and teaching to a assessment of the and of the our and Methods: of our which the the of the was to to the of a to of of of and our The that of during the with and an to side due to the Conclusion: of patients our teaching during the and an to on some to be for this should be to detect and as to prevent and There a for Department of Infectious India Background: like and were during the to be due to Methods: patients a for for been the of and with that patients who were for a on which has some with and may have a for and to of a patient as the of the has and the for to or is can be to of and in a for Department of Medical and to be Puducherry, India Background: of is an and global levels the for evolution and In this the present study was to the of the from a in Methods: that are for by with the & of – were as the for A of the were which from to from the second 2021 to and from 2021 to February were to identified that be of of and uncommon of than to be major was identified as uncommon as per The uncommon in second the identified were and few uncommon the and The in our study was and The study a of and The were in and of the a of was in which is a for and Conclusion: The study reported a of in for and in The in the for on and to However, the presented the on and increase the of the and the of The the for to the due to the of or of and with in with A Study Department of India Institute of Medical India Background: The of to the of an There is showing levels of in It has been suggested that on to The present study was to assess the in and levels in patients with diagnosed tuberculosis and to study the between levels and Methods: and levels were in patients with diagnosed tuberculosis the of of the of and the of treatment. There was a between the levels of and However, no was between and levels or between and levels with in patients with Conclusion: levels and levels were and there was an increase treatment. However, there was no between the levels of and or with the of the of and of a Institute in Kumar, Department of Medicine, Medical India Introduction: of by to in all the health to and all the to be management of the of the infectious disease. of to we to and To of in during 2 and monthly and Methods: we of all the in is to for and our a in may a of when during of there was a in the was than the and that can be assessed by monthly may as a of Conclusion: In this of when few of the for of we can a of of a which may not have been in we potential of by we be to of by the and Case of as to be in a Department of India Background: patients with are can present in a patient as and management is no than that in of HIV patients on organ transplant and and Clinical is with some with with features of for few days. presentations and and These patients are diagnosed on on and A in or of infection is with B and for 4 weeks in and in and A such as patients not due to in our can be with Amphotericin B is B the is associated with improved patient was not on presented with and in with The on like a and study and suggested the was started on with to have a India and The patient improved with therapy clinically and on is with Amphotericin B and to with and improved in Department of Medicine, India Introduction: present a case of in a with no other identified risk To the clinical and of infections in with and Methods: Case Report year to have 2 presented with of of of and to while was were was was in and were and was were for of of done showed done showed the of was done was than with and An of to was and started on were for was and was started on and was started on 4 was was and was with for 4 weeks to oral for weeks was and was on The of Amphotericin B and has the to clear the infection. is an infection of and infection of and in the risk of and of infection and and of and that are to cause to cause to and the global is as a major to global public The is and global and or and many other to antifungals and health as a and is to than the In one of with and There are associated with of the like and and and a scientific between immune and and diseases. of solid and are of the origin of associated a of have to the by which immune health Early in can to in of specific microbes can and in and clinical study on showed that of and on the can be on to of the by and are to the of the in as may with potential for for or on the of A study showed that of with including and resistance. the and of there be for by and to to in and clinical Early approach and improved health be to and There is a for global clinical that the and from and during the year of of that the in to a from a particularly which is particularly in This is presented on & May in a from India Department of and Laboratory, India Background: is in of or in immunocompromised patients in of present a case in a with no cause of This is the case from India, and the from Methods: The patient presented with for 4 for and was in were in to in the and was of were was showed and to in and were and India were all in which was identified by was by an as per A PCR on The patient was started on and to prevent the of was was with and on and Conclusion: in of patients cannot be as and be have this case not for a diagnosis and clinical on the of the in Department of Clinical India Introduction: is a cause of and mortality therapy should be by the of are with of A diagnostic is the which of and from are in an with on and of or other and have been the diagnostic tools for the of Diagnosis of is on clinical and features and not be in all of for in and Methods: The study from patients of which 50 patients from followed by 50 patients from was to detect and than is to detect with such as and In of cases and were between infectious and clinical us an to management in with infectious clinical and clinical to the of and improve of to and of Care Department of Institute of Medical Karnataka, India Introduction: is an important for the of health associated infection, which is major in and of resistance. (1) To to (2) To of method followed by and after To detect the of the recovered from swab and Methods: were for the of for 20 as per were from and after were on and was done by method as per count was done by was as per In a of no to was in while was to be and Klebsiella pneumoniae and Klebsiella pneumoniae showed to followed by were However, the count showed on between and Conclusion: to was to be The to be evaluated and The in count of and was not as per which be due to varied like not all of of after of and and is the of the Associated Department of Clinical Medicine, India and have been associated with a of including in and thrombocytopenia with disseminated or is considered the diagnosis of with A of than 50 cases of associated reported In cases, for or other was started to as the diagnosis of was only only a increase in count was therapy or to in a count a from 2 to our of managing cases of associated in the one of the cases to thrombocytopenia diagnosis was only in the all cases showed of with only with no to can present as with It should be considered as an underlying cause of in the appropriate clinical Diagnosis of can be and empirical has to be started on the Early diagnosis of and initiation of is for rapid count and can the associated with of in associated A in Department of India is a infectious by a It is an endemic in and reported from This study was to the risk clinical presentations associated with Methods: It is study of cases of from a The cases of were from from of The from to was were no patient was of cases were presented to the in from to with of and were major risk was The organ liver and were followed by disseminated and patients were with antibiotics as therapy followed by oral as Conclusion: is an infection in India in the with is to develop the infection with and are risk The clinical may from organ to with The diagnosis and prompt role in managing The of 2 Department of Infectious India Background: It is important to and which when both for 2 of Methods: A year patient with the of 2 for of the to have and with and the and presented to our after a from the showed and This may or may not have been the the infection. no was and were weeks a both the The patient was with and – by and infections have to be in when with This case highlights that the may not the from the The in the was a as the patient may have been using to and the was the The to be a a to the which was a A Rare Case of by Department of Institute of Medical India Introduction: is a rare of the as generally in infections are by and to and Case A year presented with of and in the Clinical a of in the of and nodules in the The was showed in the with for and no with no of features of a showed solid to an The was and was for and and was started on and The on agar The was identified as by of the per and was started and was 4 weeks the patient present with and was started on for 2 Discussion: are as important in The reported are followed by and infections have been reported from swab and regimens are ineffective as many antibiotics are and in such as with is in a case of the role of in infection is A of Cases of by from India Department of Infectious Diseases and of Medicine, India Background: are rare of with present cases of from Methods: the clinical and of the patients in our with The patient presented to us with fever and the second with and while the presented in a The patients for which they therapy of them were showed and findings of Central were The diagnosis of was done by and a therapy with and The second patient The cases to the therapy and the patient and is a rare with a mortality diagnosis and prompt initiation of therapy may the the unusual of cases in a of one from one of India is It is to health the and diagnosis and to a PCR – and Department of Infectious India Background: present a case the infection PCR was for as as for certain Methods: 1: This case highlights the of the It may be useful for certain infections the the It may be useful to have in the to in diverse The Case of A Case Report Department of Medicine, Medical Bengaluru, Karnataka, India is in our clinical and of them have a on few can be to for a of we a case of a from the with and from of and presentations of and was to a for a recent of for which analysis were to progressive of the PUO not to disorder and were reported to be a prolonged for weeks and an exploration and of the due to the diagnosis of was on and to in with was an is the are diagnosis to appropriate for prolonged can present with in of with as the is a rare patients with this case is for as is one of the infections and should be in the patients from endemic to and mortality of for of from a in India of and Care Medicine, Bengaluru, Karnataka, India Background: infections have as a and of the is of clinical The of or with on the This study was to the of in a using the Methods: A study was from 2019 to April 2023 in the of a Clinical that to by 2 were for The and clinical of the patients were from the the on from patients from than one The was The of to was The of was and the mortality rate was The study from 4 and 2 A of of were from Klebsiella was to be the followed by pneumoniae with of OXA-48 and were followed by and Conclusion: In our pneumoniae was the with of OXA-48 and is a for rapid of the to therapy and infecti
Zitieren
APA
(2023). CIDSCON 2023 Selected Abstracts. Journal of Clinical Infectious Diseases Society. https://doi.org/10.4103/3333-5555.380637
Vancouver
CIDSCON 2023 Selected Abstracts. Journal of Clinical Infectious Diseases Society. 2023. doi:10.4103/3333-5555.380637
BibTeX
@article{euvimed2023,
title = {CIDSCON 2023 Selected Abstracts},
journal = {Journal of Clinical Infectious Diseases Society},
year = {2023},
doi = {10.4103/3333-5555.380637}
}
EUVIMED